CCL2 and metabolic dysfunction-associated steatohepatitis: Conversely, in the development of nonalcoholic steatohepatitis, there is an upregulation of CCL2 and its receptor in the liver, facilitating macrophage recruitment, inflammation, steatosis and fibrosis, as well as in adipose tissue (33).